Journal of Shanghai Jiao Tong University (Medical Science) >
Evaluative value of plasma fibrin degradation product in early prognosis of patients with hemorrhagic stroke
Online published: 2021-05-27
Supported by
National Natural Science Foundation of China(91749126);Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Grant Support(20161408)
·To investigate the value of plasma fibrin degradation product (FDP) in assessing the risk of death within 14 d after hemorrhagic stroke (HS) onset.
·The general information, baseline laboratory parameters, surgical conditions and 14-day prognosis information of the patients with HS admitted to the Department of Emergency, North Branch of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine from May 1, 2017 to May 1, 2020 were retrospectively studied to analyze the factors associated with the patients' 14-day prognosis, and multivariate Logistic regression analysis was performed. The patients were then divided into intracerebral hemorrhage (ICH) group, primary intraventricular hemorrhage (PIVH) group and subarachnoid hemorrhage (SAH) group; the ICH group was divided into four subgroups, i.e., simple hematoma subgroup, ICH+intraventricular hemorrhage (IVH) subgroup, ICH+SAH subgroup, and ICH+IVH+SAH subgroup. Differences in the plasma FDP level between the patients who died and those who survived within 14 d were analysed separately for each group and subgroup.
·A total of 606 patients with HS were included, with an average age of (58.9 ± 15.1) years, including 405 males and 201 females. There were 493 cases in the ICH group, 32 cases in the PIVH group and 81 cases in the SAH group; in the ICH group, 254 cases were in the simple hematoma subgroup, 142 cases were in the ICH+IVH subgroup, 49 cases were in the ICH+SAH subgroup and 48 cases were in the ICH+IVH+SAH subgroup. A total of 124 patients received surgical treatment. Eighty-five patients died within 14 d of onset. The plasma FDP level [2.07 (0.92, 5.65) μg/mL] was significantly higher in the patients who died within 14 d compared with those who survived [1.12 (0.70, 2.23) μg/mL] (P=0.000), and multivariate Logistic regression analysis showed that plasma FDP>2.78 μg/mL was an independent risk factor for death within 14 d (OR=2.564, P=0.001). Group analysis revealed that the plasma FDP level of the dead patients were significantly higher than those of the surviving patients in both the ICH group [2.09 (1.00, 5.34) μg/mL vs 1.06 (0.70, 1.86) μg/mL, P=0.000] and the PIVH group [4.25 (1.49, 5.91) μg/mL vs 1.20 (0.64, 2.30) μg/mL, P=0.041]. Subgroup analysis revealed that in the ICH+IVH subgroup, the plasma FDP level of the dead patients [2.09 (1.00, 5.58) μg/mL] was significantly higher than that of the surviving ones [1.26 (0.90, 2.21) μg/mL, P = 0.027].
·Plasma FDP>2.78 μg/mL may predict a higher risk of death within 14 d in the patients with HS, especially in those with PIVH or ICH combined with IVH.
Xu-guang CHEN , Sheng-yi SHI , Lan HU , Yu CHEN , Yi-ming LU , Jing YE . Evaluative value of plasma fibrin degradation product in early prognosis of patients with hemorrhagic stroke[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2021 , 41(5) : 612 -616 . DOI: 10.3969/j.issn.1674-8115.2021.05.008
1 | Pinho J, Costa AS, Araújo JM, et al. Intracerebral hemorrhage outcome: a comprehensive update[J]. J Neurol Sci, 2019, 398: 54-66. |
2 | MacKey J, Khoury JC, Alwell K, et al. Stable incidence but declining case-fatality rates of subarachnoid hemorrhage in a population[J]. Neurology, 2016, 87(21): 2192-2197. |
3 | GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980?2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1736-1788. |
4 | Lauridsen SV, Hvas AM, Sandgaard E, et al. Coagulation profile after spontaneous intracerebral hemorrhage: a cohort study[J]. J Stroke Cerebrovasc Dis, 2018, 27(11): 2951-2961. |
5 | Fujii Y, Takeuchi S, Harada A, et al. Hemostatic activation in spontaneous intracerebral hemorrhage[J]. Stroke, 2001, 32(4): 883-890. |
6 | Abulhasan YB, Alabdulraheem N, Simoneau G, et al. Mortality after spontaneous subarachnoid hemorrhage: causality and validation of a prediction model[J]. World Neurosurg, 2018, 112: e799-e811. |
7 | Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century[J]. Stroke, 2013, 44(7): 2064-2089. |
8 | Kawano-Castillo J, Ward E, Elliott A, et al. Thrombelastography detects possible coagulation disturbance in patients with intracerebral hemorrhage with hematoma enlargement[J]. Stroke, 2014, 45(3): 683-688. |
9 | Chen CW, Wu EH, Huang J, et al. Dynamic evolution of D-dimer level in cerebrospinal fluid predicts poor outcome in patients with spontaneous intracerebral hemorrhage combined with intraventricular hemorrhage[J]. J Clin Neurosci, 2016, 29: 149-154. |
10 | Kogan AE, Mukharyamova KS, Bereznikova AV, et al. Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products[J]. Blood Coagul Fibrinolysis, 2016, 27(5): 542-550. |
11 | Wu Y, Xiao YX, Huang TY, et al. What makes D-dimer assays suspicious-heterophilic antibodies?[J]. J Clin Lab Anal, 2019, 33(2): e22687. |
12 | Boluijt J, Meijers JC, Rinkel GJ, et al. Hemostasis and fibrinolysis in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review[J]. J Cereb Blood Flow Metab, 2015, 35(5): 724-733. |
13 | Lauridsen SV, Hvas CL, Sandgaard E, et al. No hyperfibrinolysis following subarachnoid or intracerebral haemorrhage: a prospective cohort study[J]. Blood Coagul Fibrinolysis, 2019, 30(7): 341-349. |
14 | Fukuda H, Lo B, Yamamoto Y, et al. Plasma D-dimer may predict poor functional outcomes through systemic complications after aneurysmal subarachnoid hemorrhage[J]. J Neurosurg, 2017, 127(2): 284-290. |
15 | Larsen CC, Hansen-Schwartz J, Nielsen JD, et al. Blood coagulation and fibrinolysis after experimental subarachnoid hemorrhage[J]. Acta Neurochir (Wien), 2010, 152(9): 1577-1581. |
16 | Ji Y, Meng QH, Wang ZG. Changes in the coagulation and fibrinolytic system of patients with subarachnoid hemorrhage[J]. Neurol Med Chir (Tokyo), 2014, 54(6): 457-464. |
17 | Garton T, Hua Y, Xiang JM, et al. Challenges for intraventricular hemorrhage research and emerging therapeutic targets[J]. Expert Opin Ther Targets, 2017, 21(12): 1111-1122. |
18 | Wilkinson DA, Pandey AS, Thompson BG, et al. Injury mechanisms in acute intracerebral hemorrhage[J]. Neuropharmacology, 2018, 134(Pt B): 240-248. |
/
〈 |
|
〉 |